Powered by 
Google Übersetzer
Google Übersetzer
Solanbridge Group Inc Conference
Call Recap
Company Outlined Current Status of Canadian Projects
November 3, 2015
Houston – Solanbridge Group Inc (OTC: SLNX) is pleased to announce that it held a telephone conference call on Thursday, October 29th at 8:30 a.m. CDT to review its quarterly financials and report. Mr. Earle G. Hickey of Solanbridge Group Nova Scotia pointed out that medical marijuana opportunities in Canada have recently reopened based upon the recent federal election outcome. With the change from a Conservative to a Liberal government the Company sees a door opening that had previously been closed to it.
Hickey pointed out that the Company has been talking to 14 Eastern Canadian First Nations. Of those 14, five are no longer actively negotiating with the Company. Six First Nations are current open files and there are three with whom the Company is working on a day to day basis.
Hickey indicated that the plans for each of the three First Nations will employ 178 employees at each facility, based upon similar configurations.
Hickey indicated that the after the results of the federal election in Canada the team in Nova Scotia has a renewed energy and enthusiasm for the work they doing.
If you missed the telephone conference call and you would like hear the call, please contact Charles R Shirley, SLNX CEO, and he will provide you with a copy.
About Hemp
Hemp has trace or zero measurable levels of the psychoactive compound tetrahydrocannabinol (THC). There are few plants such as hemp that have so many practical uses. Hemp seeds can be used to make several health food products. Edible oil rich in polyunsaturated fatty acids is derived from these seeds through cold-press techniques. The press cake can then be milled and grounded into protein powder.
About Solanbridge Group
Inc
Solanbridge Group Inc, based in The Woodlands, Texas, is a diversified
holding company looking to expand into the medical marijuana industry by
developing commercial grower’s licenses in Eastern Canadian medical marijuana
jurisdictions, with the partnership of First Nations and developing CBD-infused
products in Colorado and Nevada. Solanbridge is also pursuing other
acquisitions in the growing medical marijuana field and partnerships with
agribusiness entities in California and Michigan.
This
release includes "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended. This presentation contains forward-looking
statements that involve substantial risks and uncertainties. You can identify
forward-looking statements by words such as anticipate, believe, could,
estimate, expect, intend, may, plan, should, will, would or similar words. You
should consider these statements carefully because they discuss our plans,
targets, strategies, prospects and expectations concerning our business,
operating results, financial condition and other similar matters. We believe
that it is important to communicate our future expectations to our investors.
There may be events in the future, however, that we are not able to predict
accurately or control. Our actual results may differ materially from the
expectations we describe in our forward looking statements. Factors or events
that could cause our actual results to materially differ may emerge from time
to time, and it is not possible for us to accurately predict all of them.
Before you invest in our common stock, you should be aware that the occurrence
of any such event could have a material adverse effect on our business, results
of operation and financial position. Any forward-looking statement made by us
in this presentation speaks only as of the date on which we make it. We
undertake no obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as
required by law.
Contact:
For further information, please contact:
Charles R.
Shirley
Solanbridge
Group Inc
832.225.1372